Attention-Deficit/Hyperactivity Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Age 7~18 years; 2: Meet the diagnostic criteria for attention deficit hyperactivity disorder (ADHD) in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); 3: Participants and legal guardians sign written informed consent to confirm their voluntary participation in the study; 4: No history of diagnosis of other neurodevelopmental disorders, serious physical diseases or comorbidities; 5: Normal visual and auditory function (corrected visual acuity >=1.0, pure tone audiometry threshold =4 weeks; 8: There was no known diagnosis of specific diseases other than ADHD.
Exclusion criteria
Exclusion criteria: 1: Failure to meet the above inclusion criteria; 2: Age >18 years; 3: Comorbid neurodevelopmental disorders (e.g., autism spectrum disorder, intellectual disability); 4: History of chronic neurological diseases (e.g., epilepsy) or severe systemic diseases (e.g., cancer); 5: Subjects with severe mental disorders (e.g., schizophrenia) or family history of psychosis; 6: Skull defects at stimulation sites or severe scalp infections; 7: History of craniotomy, any photosensitivity or metal implants in head/body (e.g., cochlear implants, pacemakers or defibrillators), or severe neurological disorders (e.g., brain tumors and intracranial infections); 8: Current use of benzodiazepines, neuroleptics and antipsychotics (e.g., risperidone and haloperidol); 9: Participation in other clinical trials within the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| integrated value of oxygenated hemoglobin concentration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective level of attention concentration;ADHD-RS-IV questionnaire; | — |
Countries
China
Contacts
Chengdu Second People's Hospital